Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2001 Jan 15;353(Pt 2):193–198. doi: 10.1042/0264-6021:3530193

Dual DNA-binding specificity of peroxisome-proliferator-activated receptor gamma controlled by heterodimer formation with retinoid X receptor alpha.

M Okuno 1, E Arimoto 1, Y Ikenobu 1, T Nishihara 1, M Imagawa 1
PMCID: PMC1221558  PMID: 11139380

Abstract

The peroxisome-proliferator-activated receptor gamma (PPARgamma) is a member of the steroid/thyroid nuclear receptor superfamily of ligand-activated transcription factors. PPARgamma forms a heterodimer with the retinoid X receptor alpha (RXRalpha) and binds to a common consensus response element consisting of a direct repeat of two hexanucleotides spaced by one nucleotide (DR1 motif). However, other hexamer configurations for binding of PPARgamma have not been considered. By using PCR-mediated random site selection, the DNA sequence preferences for PPARgamma binding were examined. In this study, we have demonstrated that PPARgamma has dual DNA-binding specificity; binding to both the DR1 motif and a palindromic sequence with three bases as spacers (Pal3 motif). The consensus sequence selected by equimolar amounts of PPARgamma and RXRalpha was a perfect DR1 motif, whereas a relatively large population of Pal3 was observed when a 30-fold molar excess of PPARgamma over RXRalpha was used. Gel-shift analysis revealed that the PPARgamma homodimer could bind to Pal3 and that the affinity constant of the PPARgamma homodimer for Pal3 was nearly the same as that of the PPARgamma/RXRalpha heterodimer for DR1. The addition of RXRalpha decreased the binding affinity of PPARgamma for Pal3, indicating that the DNA-binding specificity of PPARgamma could be altered by heterodimer formation with RXRalpha.

Full Text

The Full Text of this article is available as a PDF (444.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crandall D. L., Busler D. E., Novak T. J., Weber R. V., Kral J. G. Identification of estrogen receptor beta RNA in human breast and abdominal subcutaneous adipose tissue. Biochem Biophys Res Commun. 1998 Jul 30;248(3):523–526. doi: 10.1006/bbrc.1998.8997. [DOI] [PubMed] [Google Scholar]
  2. Deslypere J. P., Verdonck L., Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab. 1985 Sep;61(3):564–570. doi: 10.1210/jcem-61-3-564. [DOI] [PubMed] [Google Scholar]
  3. Hankinson S. E., Willett W. C., Manson J. E., Hunter D. J., Colditz G. A., Stampfer M. J., Longcope C., Speizer F. E. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995 Sep 6;87(17):1297–1302. doi: 10.1093/jnci/87.17.1297. [DOI] [PubMed] [Google Scholar]
  4. IJpenberg A., Jeannin E., Wahli W., Desvergne B. Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element. J Biol Chem. 1997 Aug 8;272(32):20108–20117. doi: 10.1074/jbc.272.32.20108. [DOI] [PubMed] [Google Scholar]
  5. Inoue S., Kondo S., Hashimoto M., Kondo T., Muramatsu M. Isolation of estrogen receptor-binding sites in human genomic DNA. Nucleic Acids Res. 1991 Aug 11;19(15):4091–4096. doi: 10.1093/nar/19.15.4091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Issemann I., Prince R. A., Tugwood J. D., Green S. The retinoid X receptor enhances the function of the peroxisome proliferator activated receptor. Biochimie. 1993;75(3-4):251–256. doi: 10.1016/0300-9084(93)90084-6. [DOI] [PubMed] [Google Scholar]
  7. Kliewer S. A., Umesono K., Noonan D. J., Heyman R. A., Evans R. M. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature. 1992 Aug 27;358(6389):771–774. doi: 10.1038/358771a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lemberger T., Desvergne B., Wahli W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol. 1996;12:335–363. doi: 10.1146/annurev.cellbio.12.1.335. [DOI] [PubMed] [Google Scholar]
  9. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mizutani T., Nishikawa Y., Adachi H., Enomoto T., Ikegami H., Kurachi H., Nomura T., Miyake A. Identification of estrogen receptor in human adipose tissue and adipocytes. J Clin Endocrinol Metab. 1994 Apr;78(4):950–954. doi: 10.1210/jcem.78.4.8157726. [DOI] [PubMed] [Google Scholar]
  11. Mosselman S., Polman J., Dijkema R. ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996 Aug 19;392(1):49–53. doi: 10.1016/0014-5793(96)00782-x. [DOI] [PubMed] [Google Scholar]
  12. Nishikawa J., Kitaura M., Matsumoto M., Imagawa M., Nishihara T. Difference and similarity of DNA sequence recognized by VDR homodimer and VDR/RXR heterodimer. Nucleic Acids Res. 1994 Aug 11;22(15):2902–2907. doi: 10.1093/nar/22.15.2902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. När A. M., Boutin J. M., Lipkin S. M., Yu V. C., Holloway J. M., Glass C. K., Rosenfeld M. G. The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors. Cell. 1991 Jun 28;65(7):1267–1279. doi: 10.1016/0092-8674(91)90021-p. [DOI] [PubMed] [Google Scholar]
  14. Palmer C. N., Hsu M. H., Griffin H. J., Johnson E. F. Novel sequence determinants in peroxisome proliferator signaling. J Biol Chem. 1995 Jul 7;270(27):16114–16121. doi: 10.1074/jbc.270.27.16114. [DOI] [PubMed] [Google Scholar]
  15. Pedersen S. B., Hansen P. S., Lund S., Andersen P. H., Odgaard A., Richelsen B. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest. 1996 Apr;26(4):262–269. doi: 10.1046/j.1365-2362.1996.145278.x. [DOI] [PubMed] [Google Scholar]
  16. Price T. M., O'Brien S. N. Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. J Clin Endocrinol Metab. 1993 Oct;77(4):1041–1045. doi: 10.1210/jcem.77.4.8408452. [DOI] [PubMed] [Google Scholar]
  17. Rastinejad F., Perlmann T., Evans R. M., Sigler P. B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 1995 May 18;375(6528):203–211. doi: 10.1038/375203a0. [DOI] [PubMed] [Google Scholar]
  18. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 1994 May 15;8(10):1224–1234. doi: 10.1101/gad.8.10.1224. [DOI] [PubMed] [Google Scholar]
  19. Tontonoz P., Hu E., Spiegelman B. M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994 Dec 30;79(7):1147–1156. doi: 10.1016/0092-8674(94)90006-x. [DOI] [PubMed] [Google Scholar]
  20. Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991 Jun 28;65(7):1255–1266. doi: 10.1016/0092-8674(91)90020-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES